129 related articles for article (PubMed ID: 24772587)
1. The quality of life in implantable cardioverter defibrillator patients.
Suwanpasak A; Boonyapisit W
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S108-14. PubMed ID: 24772587
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
Borne RT; Varosy PD; Masoudi FA
JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
[TBL] [Abstract][Full Text] [Related]
4. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
5. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
Udlis KA
J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
[TBL] [Abstract][Full Text] [Related]
7. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
8. Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator.
Habibović M; van den Broek KC; Theuns DA; Jordaens L; Alings M; van der Voort PH; Pedersen SS
Europace; 2011 Dec; 13(12):1723-30. PubMed ID: 21821854
[TBL] [Abstract][Full Text] [Related]
9. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
[TBL] [Abstract][Full Text] [Related]
10. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.
Newman DM; Dorian P; Paquette M; Sulke N; Gold MR; Schwartzman DS; Schaaf K; Wood K; Johnson L;
Am Heart J; 2003 May; 145(5):841-6. PubMed ID: 12766741
[TBL] [Abstract][Full Text] [Related]
11. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
[TBL] [Abstract][Full Text] [Related]
12. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
[TBL] [Abstract][Full Text] [Related]
13. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
14. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
[TBL] [Abstract][Full Text] [Related]
15. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
[TBL] [Abstract][Full Text] [Related]
16. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
17. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death.
Verkerk AJ; Vermeer AM; Smets EM; Dekker LR; Wilde AA; Van Langen IM; Christiaans I; Nieuwkerk PT
Pacing Clin Electrophysiol; 2015 Jul; 38(7):870-7. PubMed ID: 25880250
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter defibrillators in patients with valvular cardiomyopathy.
Valles AG; Khawaja FJ; Gersh BJ; Enriquez-Sarano M; Friedman PA; Park SJ; Hodge DO; Cha YM
J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1326-32. PubMed ID: 23130974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
